FDA Inspection 1162394 — UCLA Health, UCLA Blood & Platelet Center
The FDA completed an inspection of UCLA Health, UCLA Blood & Platelet Center on February 10, 2022 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Los Angeles, CA (United States)